$3.75
-0.02-0.53%
Pre-Market: 4:22 PM EDT
Mural Oncology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Mural Oncology using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-13 | $-1.87 | $-1.95 | 4.10 % |
Q2 | 2024-08-13 | $-1.86 | $-1.90 | 2.11 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mural Oncology (MURA) is scheduled to report earnings on March 25, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
The Actual EPS was $-1.87, which beat the estimate of $-1.95.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.